The overall goal of this project is to understand how opioids and the neuropeptide, substance P (SP), operate as central mediators in the interaction between the immune system and the nervous system and in the immunopathogenesis of HIV infection and AIDS. Our overarching hypothesis is that SP and the SP receptor(neurokinin-1 receptor, NK-1R) are biologically involved in opioid- or opioid withdrawal-mediated immune modulation related to the immunopathogenesis of HIV infection and AIDS. We predict that SP levels in the circulating blood and peripheral tissues increase as a result of opioid abuse, which results in immune suppression and enhanced HIV infection of the human immune cells and that opioid withdrawal accentuates this effect. In our ongoing studies (DA12815), we have demonstrated that opioid-dependent subjects attending a methadone treatment program have increased levels of circulating plasma SP and expression of SP mRNA in PBMC in comparison to normal subjects. These unique and novel observations constitute a compelling rationale for the continuation of our studies characterizing the role of opioids and/or SP in the immunopathogenesis of HIV infection and AIDS. Furthermore, these findings provide the basis for new detailed mechanistic studies into the biologic interaction between opioids and SP in the CNS and human immune systems.
In Aims 1 -2, we propose new in vitro studies that will extend our existing in vitro models using cells from the human immune system and CNS in order to investigate the interaction between opioids, SP and HIV. These new in vitro studies will provide physical evidence as well as insight into the molecular mechanisms of the interaction of opioids and/or SP with HIV in both human immune and CNS cells. The impact of opioid withdrawal on the expression of SP and NK-1R, as well as the immune function related to HIV infection, also will be a new focus of the proposed study. We propose new ex vivo studies (Aim 3) to examine the role of opioids and/or SP in suppression of host innate immunity against HIV infection and in the activation of HIV in latently-infected immune cells. We will further characterize the in vivo relationship between opioids, SP and immune function using specimens from HIV + and HIV opioid-dependent subjects(Aim 4a). In addition, we will examine the role of in vivo opioid withdrawal in modulation of immune cell function, the expression of SP/NK-1R and HIV/HCV viral loads (Aim 4b). The proposed studies represent a unique series of experiments directed toward elucidating the host defense processes and the role of opioids abuse in HIV infection of human immune cells as well as in HCV infection, which will ultimately further the design and development of improved treatment regimens for substance-abusing subjects. ? ? ? ?
|Zhou, Yu; Sun, Li; Wang, Xu et al. (2016) Short Communication: HIV-1 Infection Suppresses Circulating Viral Restriction microRNAs. AIDS Res Hum Retroviruses 32:386-9|
|Zhou, Yu; Sun, Li; Wang, Xu et al. (2015) Heroin use promotes HCV infection and dysregulates HCV-related circulating microRNAs. J Neuroimmune Pharmacol 10:102-10|
|Zhou, Li; Li, Jie-Liang; Zhou, Yu et al. (2015) Induction of interferon-? contributes to TLR3 and RIG-I activation-mediated inhibition of herpes simplex virus type 2 replication in human cervical epithelial cells. Mol Hum Reprod 21:917-29|
|Wang, Yizhong; Li, Jieliang; Wang, Xu et al. (2015) Comparison of antiviral activity of lambda-interferons against HIV replication in macrophages. J Interferon Cytokine Res 35:213-21|
|Wang, Yizhong; Li, Jieliang; Wang, Xu et al. (2014) Hepatitis C virus impairs TLR3 signaling and inhibits IFN-? 1 expression in human hepatoma cell line. Innate Immun 20:3-11|
|Mastrogiannis, Dimitrios S; Wang, Xu; Dai, Min et al. (2014) Alcohol enhances HIV infection of cord blood monocyte-derived macrophages. Curr HIV Res 12:301-8|
|Sang, Ming; Liu, Jin-Biao; Dai, Ming et al. (2014) Toll-like receptor 3 signaling inhibits simian immunodeficiency virus replication in macrophages from rhesus macaques. Antiviral Res 112:103-12|
|Wang, Yizhong; Li, Jieliang; Wang, Xu et al. (2013) Hepatic stellate cells, liver innate immunity, and hepatitis C virus. J Gastroenterol Hepatol 28 Suppl 1:112-5|
|Li, Jieliang; Wang, Yizhong; Wang, Xu et al. (2013) Immune activation of human brain microvascular endothelial cells inhibits HIV replication in macrophages. Blood 121:2934-42|
|Zhou, Yu; Guo, Ming; Wang, Xu et al. (2013) TLR3 activation efficiency by high or low molecular mass poly I:C. Innate Immun 19:184-92|
Showing the most recent 10 out of 83 publications